Core Viewpoint - Newnow (300765) has appointed a new general manager and board secretary, both born in the 1990s, but the market reacted negatively, with the stock price dropping by up to 18% in early trading. The company also announced a significant expected net profit decline for 2025, with a decrease of 416% to 575% compared to the same period in 2024 [1]. Group 1 - The new general manager, Dai Long, born in June 1992, has a bachelor's degree and joined Newnow in December 2016, holding multiple roles including financial manager, securities affairs representative, and board secretary [1]. - Despite holding several positions, Dai Long's pre-tax compensation for 2024 was only 223,200 yuan [1]. - Newnow's main business focuses on the research, production, and sales of biopharmaceuticals and functional foods and raw materials, with a focus on cutting-edge areas such as ADC, mRNA vaccines, and antibody drugs [1].
新诺威迎“90后”总经理,此前兼任公司董秘、证代和财务总监,年薪仅22万元